INTERNATIONAL PATENT: ELI LILLY AND COMPANY FILES APPLICATION FOR "RXFP1 RECEPTOR AGONISTS"

GENEVA, May 28 -- ELI LILLY AND COMPANY (LILLY CORPORATE CENTERIndianapolis, Indiana 46285) filed a patent application (PCT/US2024/056074) for "RXFP1 RECEPTOR AGONISTS" on Nov 15, 2024. With publication no. WO/2025/106780, the details related to the patent application was published on May 22, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ANDERSON, Erin (c/o Eli Lilly and Company,PO Box 6288Indianapolis, Indiana 46206-6288), CALDWELL JR., Donald Raymond (c/o Eli Lilly and Company,PO Box 6288Indianapolis, Indiana 46206-6288), FIELDS, Todd (c/o Eli Lilly and Company,PO Box 6288Indianapolis, I...